{
    "nct_id": "NCT05588063",
    "official_title": "A Pilot Randomized Clinical Trial of Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Frequently Relapsing Nephrotic Syndrome in Children",
    "inclusion_criteria": "* FRNS\n* Age 3-17 years\n* Glomerular filtration rate (eGFR) ≥30 ml/min/1.73 m2\n* Minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS) diagnosis (clinical diagnosis or per biopsy)\n* Steroid sensitive nephrotic syndrome (prior history of remission within 4 weeks of steroid therapy)\n* In remission at time of enrollment (remission defined as UPC <0.2 or negative dipstick for 3 consecutive days)\n* Informed consent from the parent or guardian and assent from a minor of ≥ 7. years\nHealthy volunteers allowed\nMust have minimum age of 3 Years\nMust have maximum age of 17 Years",
    "exclusion_criteria": "* Secondary forms of nephrotic syndrome\n* SRNS\n* Steroid dependent nephrotic syndrome (relapse within 14 days of stopping steroids or relapse while on steroids)\n* Exposure to steroids within 14 days of enrollment\n* Receiving any standing immunosuppression (previous exposure > 2 months allowed and/or B cell repletion)\n* Any known inflammatory condition (e.g. systemic lupus erythematosis)\n* History of cardiac disease (arrhythmias, structural/functional abnormalities)\n* Implantable electronic devices\n* Pregnancy\n* Participants/guardians or participants who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures",
    "miscellaneous_criteria": ""
}